Top Markets
Coin of the day
Genetron Holdings Limited Genetron Holdings Limited

Genetron Holdings Limited

GTH
Classifica tra le azioni #15212
Genetron Holdings Limited (GTH) is a precision oncology company that... Genetron Holdings Limited (GTH) is a precision oncology company that specializes in cancer molecular profiling, utilizing advanced molecular biology and data science to enhance cancer treatment. The company delivers a range of services, including diagnosis, monitoring, and early screening, primarily through its proprietary laboratory-developed tests. Its product offerings encompass a variety of in-vitro diagnostic (IVD) solutions. These include the 8-gene lung cancer assay, an IVD product for lung cancer detection; the Genetron 3D biochip reading instrument; and the Genetron S5, a semiconductor-based next-generation sequencing (NGS) system that identifies nucleotides by detecting pH changes. Other key products are the Genetron Chef System, the production-scale Genetron S2000 sequencing platform, and Onco PanScan, a genomic profiling service for diverse solid tumors. Moreover, Genetron provides specialized assays such as the IDH1 and TERT gene assays for glioma, a fundamental thyroid assay for thyroid tumors, a platelet-derived growth factor receptor alpha assay for GIST cancer, and HCCscan, a qPCR-based assay designed to detect hepatocellular carcinoma. Beyond its direct services and products, the company offers genomics research and clinical development services, often in collaboration with biopharmaceutical companies globally. Genetron has also established a strategic partnership with JD Health to develop holistic solutions for comprehensive cancer management. The company was founded in 2015 and has its headquarters in Beijing, People's Republic of China.
Prezzo delle azioni
$4.03
Ultima sincronizzazione: 2024-03-28
Capitalizzazione di mercato
$366.11M
Variazione (1 giorno)
0.25%
Variazione (1 anno)
0.00%
Paese
CN
Scambia Genetron Holdings Limited (GTH)

Categoria

Il prezzo GTH con la capitalizzazione del mercato della B
Genetron Holdings Limited Genetron Holdings Limited
GTH
$4.03
Capitalizzazione di mercato di Genetron Holdings Limited(GTH)
Capitalizzazione di mercato: $366.11M
A partire dal September 2026, Genetron Holdings Limited ha una capitalizzazione di mercato pari a $366.11M. Questo rende Genetron Holdings Limited la 15212th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Genetron Holdings Limited dal 2020 al 2026
GTH in paragone con la classifica dei più popolari stocks
Il prezzo per GTH Attivo B Capitalizzazione del mercato a B Risultati
Genetron Holdings Limited Genetron Holdings Limited
$58,635.34 $366.11M
$5.327T +1,454,871.21%
Genetron Holdings Limited Genetron Holdings Limited
$51,128.96 $366.11M
$4.645T +1,268,608.59%
Genetron Holdings Limited Genetron Holdings Limited
$44,803.81 $366.11M
$4.070T +1,111,657.10%
Genetron Holdings Limited Genetron Holdings Limited
$41,659.16 $366.11M
$3.785T +1,033,625.99%
Genetron Holdings Limited Genetron Holdings Limited
$30,712.57 $366.11M
$2.790T +761,998.39%